Keytruda 100 MG /4ML, ID 37690

What This Medication Is

Keytruda 100 mg/4 mL is a prescription cancer immunotherapy that oncologists use to treat several advanced and metastatic cancers. Specifically, it belongs to the PD-1 (programmed death-1) inhibitor class and therefore enhances the immune system’s ability to identify and attack cancer cells. In clinical practice, healthcare professionals administer Keytruda through intravenous (IV) infusion in a hospital or specialized oncology setting.

Active Ingredients

Each 4 mL vial contains pembrolizumab 100 mg (25 mg/mL). Importantly, pembrolizumab is a monoclonal antibody that directly targets the PD-1 receptor on immune T-cells. As a result, immune cells regain their ability to recognize and respond to cancer more effectively.

Intended Medical Use

Doctors prescribe Keytruda to strengthen immune-mediated cancer control. Depending on the diagnosis, clinicians may use it alone or combine it with other therapies. For example, approved indications include:

• Non-Small Cell Lung Cancer (NSCLC)

• Melanoma

• Head and Neck Squamous Cell Carcinoma

• Urothelial Carcinoma

• Gastric and gastro-oesophageal junction cancers

• Certain colorectal and other solid tumors

However, approved uses may vary by country, regulatory authority, and individual patient factors.

Safety Information

Because Keytruda activates the immune system, it can sometimes cause immune-related side effects. Most commonly, these reactions may affect organs such as the lungs, liver, intestines, thyroid, or skin. Therefore, patients should report symptoms like shortness of breath, severe diarrhea, persistent rash, or unusual fatigue as soon as they appear. With early recognition, clinicians can manage these effects promptly and effectively.

Who Should Not Use This

Patients should avoid Keytruda if they:

• Have a known allergy to pembrolizumab or any formulation component

• Have uncontrolled autoimmune diseases, unless a specialist approves treatment

• Are pregnant or breastfeeding, unless a physician determines the benefits outweigh the risks

Before treatment begins, a healthcare provider should carefully review the patient’s full medical history.

Storage & Handling

Healthcare facilities store Keytruda under refrigerated conditions according to manufacturer guidelines. Additionally, trained medical professionals prepare and administer the infusion. For safety reasons, patients should not store or handle this medication at home.

Authenticity & Quality Assurance

Patients should obtain Keytruda only through licensed hospitals, oncology clinics, or authorized pharmaceutical distributors. Consequently, genuine Keytruda meets strict international standards for sterility, potency, and quality.

FAQs

What is the drug KEYTRUDA used for?
KEYTRUDA treats several advanced or metastatic cancers. Specifically, it helps the immune system recognize and destroy cancer cells more effectively.

How much does KEYTRUDA cost?
KEYTRUDA pricing varies by country, treatment plan, dosage schedule, and insurance coverage. Therefore, oncology providers can supply accurate and up-to-date cost information.

How many KEYTRUDA treatments are needed?
Treatment duration depends on cancer type, patient response, and clinical guidelines. As a result, some patients receive therapy for several months, while others continue longer under close medical supervision.

What is pembrolizumab 100 mg used for?
Pembrolizumab 100 mg is used in cancer immunotherapy. In particular, it blocks the PD-1 pathway, thereby enabling immune cells to target tumors more effectively.